This article presents compelling data showing that IV chelation therapy using EDTA may contribute to a reduction in coronary artery calcium (CAC) scores—a widely used marker of cardiovascular disease risk. The content supports the hypothesis that removing heavy metals and reducing vascular calcification can improve cardiovascular outcomes, even in patients without traditional symptoms.

Why This Helps Increase Chelation Sales:

• Clinically Validates Chelation: Demonstrates how chelation isn't just for detox—it's a tool that may help reverse arterial calcification.

• Motivates Preventive Patients: Patients with high CAC scores or family history of heart disease often feel stuck—this gives them a hopeful, proactive option.

• Differentiates Your Practice: Most clinics don’t promote chelation as a heart health tool—using this article in marketing or consults sets you apart.

• Upsell Opportunity: This positions chelation as part of a longevity or cardiovascular prevention protocol, increasing the perceived value and long-term commitment.